Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter

被引：6
|
作者：
Businello, Gianluca [1 ]
Angerilli, Valentina [1 ]
Lonardi, Sara [2 ]
Bergamo, Francesca [2 ]
Valmasoni, Michele [3 ]
Farinati, Fabio [3 ]
Savarino, Edoardo [3 ]
Spolverato, Gaya [3 ]
Fassan, Matteo [1 ,2 ]
机构：
[1] Univ Padua, Dept Med DIMED, Padua, Italy
[2] Ist Ricovero & Cura Carattere Sci IRCCS, Veneto Inst Oncol, Padua, Italy
[3] Univ Padua, Dept Surg Oncol & Gastroenterol DISCOG, Padua, Italy
来源：
UPDATES IN SURGERY | 2023年 / 75卷 / 02期
关键词：
Gastric adenocarcinoma; Gastroesophageal junction adenocarcinoma; Biomarkers; Immunohistochemistry; ADVANCED GASTRIC-CANCER; TYROSINE KINASE INHIBITOR; FGFR2 GENE AMPLIFICATION; DOUBLE-BLIND; OPEN-LABEL; 1ST-LINE THERAPY; HER2; STATUS; PHASE-II; MICROSATELLITE INSTABILITY; GASTROESOPHAGEAL CANCER;
D O I：
10.1007/s13304-022-01330-5
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
The comprehensive molecular characterization of gastric and gastroesophageal junction adenocarcinomas has led to the improvement of targeted and more effective treatments. As a result, several biomarkers have been introduced into clinical practice and the implementation of innovative diagnostic tools is under study. Such assessments are mainly based on the evaluation of limited biopsy material in clinical practice. In this setting, the pathologist represents a key player in the selection of patients facilitating precision medicine approaches.
引用
收藏
页码：291 / 303
页数：13
相关论文
共 50 条
  • [31] Gastric Tube Reconstruction Reduces Postoperative Gastroesophageal Reflux in Adenocarcinoma of Esophagogastric Junction
    Xiu-Feng Chen
    Bo Zhang
    Zhi-Xin Chen
    Jian-Kun Hu
    Bin Dai
    Fang Wang
    Hong-Xin Yang
    Jia-Ping Chen
    Digestive Diseases and Sciences, 2012, 57 : 738 - 745
  • [32] Incidence of brain metastases in HER2+gastric or gastroesophageal junction adenocarcinoma
    Blay, Christophe
    Chiforeanu, Dan Cristian
    Boucher, Eveline
    Cabillic, Florian
    Desgrippes, Romain
    Leconte, Berengere
    Perrin, Christophe
    Manfredi, Sylvain
    Audrain, Odile
    Meunier, Bernard
    Edeline, Julien
    ACTA ONCOLOGICA, 2015, 54 (10) : 1833 - 1835
  • [33] Characteristics and Survival Rate of Patients with Gastric and Gastroesophageal Junction Adenocarcinoma in Yazd, Iran
    Akhavan, Ali
    Binesh, Fariba
    Seifaddiny, Azadeh
    Ghannadi, Fazloallah
    MIDDLE EAST JOURNAL OF CANCER, 2013, 4 (03) : 125 - 129
  • [34] Positioning of second-line treatment for advanced gastric and gastroesophageal junction adenocarcinoma
    Pericay, Carles
    Rivera, Fernando
    Gomez-Martin, Carlos
    Nunez, Inmaculada
    Cassinello, Alejo
    Rodrigo Imedio, Esteban
    CANCER MEDICINE, 2016, 5 (12): : 3464 - 3474
  • [35] Gastric Tube Reconstruction Reduces Postoperative Gastroesophageal Reflux in Adenocarcinoma of Esophagogastric Junction
    Chen, Xiu-Feng
    Zhang, Bo
    Chen, Zhi-Xin
    Hu, Jian-Kun
    Dai, Bin
    Wang, Fang
    Yang, Hong-Xin
    Chen, Jia-Ping
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (03) : 738 - 745
  • [36] Treatment patterns and outcomes in advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in China
    Zhang, Jingdong
    Wang, Guangyu
    Xie, Xianhe
    Pan, Wensheng
    Dong, Qian
    Zhang, Nianhai
    Dong, Jie
    Zhou, Li
    Zhou, Chan
    Li, Jinnan
    Segall, Grace
    Zhang, Yanqiao
    FUTURE ONCOLOGY, 2025,
  • [37] Multimodal Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma -ECF vs. FLOT
    Schroeder, W.
    Bruns, C. J.
    CHIRURG, 2019, 90 : S27 - S27
  • [38] Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction
    Bornschein, Jan
    Wernisch, Lorenz
    Secrier, Maria
    Miremadi, Ahmad
    Perner, Juliane
    MacRae, Shona
    O'Donovan, Maria
    Newton, Richard
    Menon, Suraj
    Bower, Lawrence
    Eldridge, Matthew D.
    Devonshire, Ginny
    Cheah, Calvin
    Turkington, Richard
    Hardwick, Richard H.
    Selgrad, Michael
    Venerito, Marino
    Malfertheiner, Peter
    Fitzgerald, Rebecca C.
    Noorani, Ayesha
    Elliott, Rachael Fels
    Edwards, Paul A. W.
    Grehan, Nicola
    Nutzinger, Barbara
    Crawte, Jason
    Chettouh, Hamza
    Contino, Gianmarco
    Li, Xiaodun
    Gregson, Eleanor
    Zeki, Sebastian
    de la Rue, Rachel
    Malhotra, Shalini
    Tavare, Simon
    Lynch, Andy G.
    Smith, Mike L.
    Davies, Jim
    Crichton, Charles
    Carroll, Nick
    Safranek, Peter
    Hindmarsh, Andrew
    Sujendran, Vijayendran
    Hayes, Stephen J.
    Ang, Yeng
    Preston, Shaun R.
    Oakes, Sarah
    Bagwan, Izhar
    Save, Vicki
    Skipworth, Richard J. E.
    Hupp, Ted R.
    O'Neill, J. Robert
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (12) : 3389 - 3401
  • [39] Gastrointestinal cancers: current biomarkers in esophageal and gastric adenocarcinoma
    Dhakras, Purabi
    Uboha, Nataliya
    Horner, Vanessa
    Reinig, Erica
    Matkowskyj, Kristina A.
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
  • [40] Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction
    Menges, Markus
    Hoehler, Thomas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (01) : 29 - 38
12345